SAFECODE DRUG TECHNOLOGIES CORP. Net Income
SAFECODE DRUG TECHNOLOGIES CORP. reported Net Income of -$236.57 thousand for the 3-month period ending 2013-06-30, per its 10-Q filed 2013-08-13.
Discontinued › Income Statement
us-gaap:NetIncomeLoss · last filed 2013-08-13
- SAFECODE DRUG TECHNOLOGIES CORP. net income (loss) attributable to parent for the quarter ending 2013-06-30 was -$236.57K.
- SAFECODE DRUG TECHNOLOGIES CORP. net income (loss) attributable to parent for the quarter ending 2013-03-31 was -$562.99K.
- SAFECODE DRUG TECHNOLOGIES CORP. net income (loss) attributable to parent for the quarter ending 2012-12-31 was -$2.03M.
- SAFECODE DRUG TECHNOLOGIES CORP. net income (loss) attributable to parent for the quarter ending 2012-09-30 was -$21.01K.
| Period end | Net Income (Loss) Attributable to Parent 1 month | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month | Net Income (Loss) Attributable to Parent 13 month | Net Income (Loss) Attributable to Parent 16 month | Net Income (Loss) Attributable to Parent 19 month | Net Income (Loss) Attributable to Parent 22 month | Net Income (Loss) Attributable to Parent 25 month | Net Income (Loss) Attributable to Parent 28 month | Net Income (Loss) Attributable to Parent 31 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013-06-30 | -$236.57K 10-Q · filed 2013-08-13 | -$799.56K 10-Q · filed 2013-08-13 | -$2.83M derived: sum of 3 quarters · filed 2013-08-13 | -$2.85M derived: sum of 4 quarters · filed 2013-08-13 | -$2.92M 10-Q · filed 2013-08-13 | |||||||
| 2013-03-31 | -$562.99K 10-Q · filed 2013-05-10 | -$2.59M derived: sum of 2 quarters · filed 2013-05-10 | -$2.61M derived: sum of 3 quarters · filed 2013-05-10 | -$2.63M derived: sum of 4 quarters · filed 2013-08-13 | -$2.68M 10-Q · filed 2013-05-10 | |||||||
| 2012-12-31 | -$2.03M derived: 10-Q 12 month − 10-Q/A 9 month · filed 2013-05-10 | -$2.05M derived: sum of 2 quarters · filed 2013-05-10 | -$2.06M derived: sum of 3 quarters · filed 2013-08-13 | -$2.06M 10-Q · filed 2013-05-10 | -$2.12M 10-K · filed 2013-03-25 | |||||||
| 2012-09-30 | -$21.01K 10-Q/A · filed 2012-12-18 | -$36.63K derived: sum of 2 quarters · filed 2013-08-13 | -$37.29K 10-Q/A · filed 2012-12-18 | -$63.20K derived: sum of 4 quarters · filed 2013-08-13 | -$90.91K 10-Q/A · filed 2012-12-18 | |||||||
| 2012-06-30 | -$15.63K 10-Q · filed 2013-08-13 | -$16.28K 10-Q · filed 2013-08-13 | -$42.19K derived: sum of 3 quarters · filed 2013-08-13 | -$47.49K derived: sum of 4 quarters · filed 2013-08-13 | -$69.90K 10-Q/A · filed 2012-12-18 | |||||||
| 2012-03-31 | -$654.00 10-Q · filed 2013-05-10 | -$26.56K derived: sum of 2 quarters · filed 2013-05-10 | -$31.86K derived: sum of 3 quarters · filed 2013-05-10 | -$35.86K derived: sum of 4 quarters · filed 2013-05-10 | -$54.27K 10-Q · filed 2012-05-15 | |||||||
| 2011-12-31 | -$25.91K derived: 10-Q 12 month − 10-Q/A 9 month · filed 2013-05-10 | -$31.21K derived: sum of 2 quarters · filed 2013-05-10 | -$35.21K derived: sum of 3 quarters · filed 2013-05-10 | -$41.86K 10-Q · filed 2013-05-10 | -$53.62K 10-K · filed 2012-03-29 | |||||||
| 2011-09-30 | -$5.30K 10-Q/A · filed 2012-12-18 | -$9.30K derived: sum of 2 quarters · filed 2012-12-18 | -$15.95K 10-Q/A · filed 2012-12-18 | |||||||||
| 2011-06-30 | -$4.00K 10-Q/A · filed 2012-12-18 | -$10.65K 10-Q/A · filed 2012-12-18 | ||||||||||
| 2011-03-31 | -$6.65K 10-Q · filed 2012-05-15 | |||||||||||
| 2010-12-31 | -$11.76K 10-Q · filed 2013-05-10 |